ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
•16 Jun 2020 11:37

Hygeia Healthcare (海吉亚) IPO: Hot Deal but Expect Tiny Allocation

Hygeia Healthcare Group, a leading oncology specialized healthcare group, started book building to raise up to USD 286 million Hong Kong...

Logo
556 Views
Share
•10 Jun 2020 10:21

Hygeia Healthcare (海吉亚) Pre-IPO: PHIP Updates and Thoughts on Valuation

Hygeia Healthcare Group, a leading oncology specialized healthcare group, started pre-marketing its USD 300 million Hong Kong listing. The company...

Logo
600 Views
Share
•17 May 2020 14:18

Hong Kong Buybacks League Table: China Evergrande, Yanzhou Coal, Jinxin Fertility

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
286 Views
Share
•02 Apr 2020 17:41

Bottom Fishing Idea - Jinxin Fertility: IVF Story Intact

Jinxin Fertility has recently reported its results on March 31st. While we don't intend to cover the full result analysis, we would like to...

Logo
501 Views
Share
•27 Feb 2020 11:07

Hygeia Healthcare (海吉亚) Pre-IPO: The Making of Jinxin in the Oncology Segment

Hygeia Healthcare Group, a leading oncology specialized healthcare group, is planning to raise to USD 500 million via a Hong Kong listing. The...

Logo
663 Views
Share
x